Dow Up 1.63% Nasdaq Up 0.97%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.33 Up 0.03(1.92%) Oct 17, 4:00PM EDT
|After Hours : 1.41 Up 0.08 (6.02%) Oct 17, 5:42PM EDT
Prev Close:1.31
Open:1.33
Bid:1.33 x 11000
Ask:1.47 x 600
1y Target Est:3.10
Beta:1.27
Next Earnings Date:N/A
Day's Range:1.25 - 1.35
52wk Range:1.07 - 5.19
Volume:2,074,900
Avg Vol (3m):1,757,300
Market Cap:187.59M
P/E (ttm):N/A
EPS (ttm):-0.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXUp 1.92%187.59M
AZNUp 0.37%85.64B
GSKUp 1.84%104.90B
PFEUp 0.47%176.47B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback